Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combined $668 million with an unidentified European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback